2.5 Pharmacokinetic, Safety, and Statistical Analyses Summary statistics and statistical analyses were based on all subjects exposed to a 0.5 mg dose of semaglutide
Injectable treatments restore these levels directly, leading to gradual yet consistent improvement in skin brightness and resilience
Wegovy, on the other hand, is specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition
It is currently available in formulations for oral and subcutaneous administration (8)
These include symptoms of pancreatitis (severe abdominal pain radiating to the back, persistent vomiting), allergic reactions (difficulty breathing, facial swelling, severe rash), or signs of thyroid tumors (neck mass, difficulty swallowing, persistent hoarseness)